Neostigmine Methylsulfate

Records for this ingredient, by country (identity only).

ATC N07AA01 · 5 markets · 128 records

Neostigmine Methylsulfate 5 markets · 128 records Forms
Filters
Kind

US 51 records · 5 shown of 5 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

  • 1 mg per mL / per unit basis not statedinjectionBloxiverzManufacturer: Amneal Pharmaceuticals LLC、Manufacturer: Amphastar Pharmaceuticals, …、Manufacturer: BE Pharmaceuticals Inc.、Manufacturer: Camber Pharmaceuticals Inc.、Manufacturer: Caplin Steriles Limited、Manufacturer: Civica, Inc.、Manufacturer: Dr.Reddy's Laboratories Inc、Manufacturer: Dr.Reddys Laboratories Inc +13
  • 0.5 mg per mL / per unit basis not statedinjectionManufacturer: Amneal Pharmaceuticals LLC ×2Manufacturer: Amphastar Pharmaceuticals, …、Manufacturer: BE Pharmaceuticals Inc.、Manufacturer: Camber Pharmaceuticals Inc.、Manufacturer: Caplin Steriles Limited、Manufacturer: Dr.Reddy's Laboratories Inc、Manufacturer: Eugia US LLC、Manufacturer: Fresenius Kabi USA, LLC、Manufacturer: Gland Pharma Limited +7
  • 1.02 mg per mL / per unit basis not statedinjectionManufacturer: Meitheal Pharmaceuticals In… ×2
  • 0.51 mg per mL / per unit basis not statedinjectionManufacturer: Meitheal Pharmaceuticals In… ×2

Combination products containing this ingredient

  • 1 mg per mL / per unit basis not statedinjection CombinationGlycopyrrolate 0.2 mg + Neostigmine Methylsulfate 1 mgPREVDUO

TW 44 records · 0 shown of 0 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

44 records · 0 manufacturers 44 registros · 0 fabricantes 44 个记录 · 0 个厂家 44 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名"信東"安可健注射液 ×1"台灣塩野義"硫酸甲酯新斯狄明點眼液0.01% ×1"杏輝" 舒明視眼藥水 ×1"派頓"保麗晶眼藥水 ×1"派頓"好明亮眼藥水 ×1"濟生"新斯狄格明注射液 ×1All-in-one eye drop "Patron" ×1BALLADE E 50 ×1

and 79 more (0 manufacturers) y 79 más (0 fabricantes) 还有 79 个(0 个厂家) 還有 79 個(0 個廠商)

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 8 records · 3 shown of 3 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

AU 7 records · 2 shown of 2 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

  • 2.5 mg per mL / per unit basis not statedinjectionNEOSTIGMINE JUNO neostigmine methylsulfate 2.5 mg/1 mL solution for injection ampoule unknown

Combination products containing this ingredient

  • 2.5 mg per mL / per unit basis not statedinjection CombinationGlycopyrronium Bromide 0.5 mg + Neostigmine Methylsulfate 2.5 mgGLNEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/ neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampouleGLYCONEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule、NOVISTIG glycopyrronium bromide (glycopyrrolate)/neostigmine methylsulfate 0.5 mg/2.5 mg per 1 mL injection solution ampoule unknown
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名GLYCONEO ×1NEOSTIGMINE JUNO ×1Novistig ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

  • 2.5 mg/mL per mL / per unit basis not statedinjectionSETISIN INJECTION 2.5 mg/ml

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.